Cloperastine (Compound)

Synonyms:cloperastine, 3703-76-2, Cloperastine [INN], 1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)piperidine, 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine, EINECS 223-042-3, HT-11, LevocloperastineIH, 69M5L7BXEK, Piperidine, 1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-, Cloperastine (hydrochloride), Cloperastine (INN), NSC-758635, Piperidine, 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)-, 1-{2-[(4-chlorophenyl)(phenyl)methoxy]ethyl}piperidine, Cloperastina, Cloperastinum, Cloperastinum [INN-Latin], Cloperastina [INN-Spanish], HT 11, UNII-69M5L7BXEK, BRN 0275589, 1-(2-[(p-Chloro-.alpha.-phenylbenzyl)oxy]ethyl)piperidine, 1-(2-((P-CHLORO-.ALPHA.-PHENYLBENZYL)OXY)ETHYL)PIPERIDINE, 1-(2-((4-Chlorophenyl)phenylmethoxy)ethyl)piperidine, cloperastine-fendizoate, Piperidine, 1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-, hydrochloride, Spectrum_001570, Prestwick0_000793, Prestwick1_000793, Prestwick2_000793, Prestwick3_000793, Spectrum2_001596, Spectrum3_001895, Spectrum4_000844, Spectrum5_001448, CLOPERASTINE [MI], BSPBio_000926, BSPBio_003430, CLOPERASTINE [MART.], KBioGR_001447, KBioSS_002050, 5-20-02-00105 (Beilstein Handbook Reference), CLOPERASTINE [WHO-DD], DivK1c_000840, SCHEMBL284715, SPBio_001592, SPBio_002865, BPBio1_001020, CHEMBL415087, 1- 2-((p-Chloro-alpha-phenylbenzyl)oxy)ethyl piperidine, 1-{2-((p-Chloro-alpha-phenylbenzyl)oxy)ethyl}piperidine, DTXSID7048532, CHEBI:94448, KBio1_000840, KBio2_002050, KBio2_004618, KBio2_007186, KBio3_002933, NINDS_000840, Piperidine, 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)-, BDBM50237287, STK646871, AKOS005577799, DB09002, NSC 758635, IDI1_000840, NCGC00178069-01, NCGC00178069-02, NCGC00178069-03, SBI-0051861.P002, AB00053681, FT-0746924, VU0244436-2, D03557, AB00053681_08, EN300-18567806, Q2055825, BRD-A80908310-003-05-4, BRD-A80908310-003-08-8, 1-[2-[(4-chlorophenyl)-phenyl-methoxy]ethyl]piperidine, 1-(2-[(4-Chlorophenyl)(phenyl)methoxy]ethyl)piperidine #, Piperidine, 1-(2-((p-chloro-.alpha.-phenylbenzyl)oxy)ethyl)-

Pubchem:PUBCHEM:2805

Id:97a5fde7-d692-58c7-9ba5-6e3bb275c90e

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Cloperastine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Cloperastine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Cloperastine.

Results found

Linked to

	Label	Description
	BRD-A80908310-003-08-8 Substance (Entity type)	A Substance
	cloperastine (38abe718-b25e-408b-891d-0540d9177f97) Collection (Entity type)	Metadatata for cloperastine
	DCSTRUCT ID 00707 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00707; PubChem_CID:2805, FILE=drugcentral_drug_00707.json)
	Cloperastine in similarity relationship with Hydroxyamphetamine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cloperastine positively regulates ANPEP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SA-1456456 in similarity relationship with Cloperastine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cloperastine negatively regulates HK2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cloperastine in similarity relationship with proxyphylline Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cloperastine negatively regulates CDKN1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Cloperastine positively regulates SRD5A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS